Ensaios Clínicos (somente visualização)

Listagem completa dos ensaios clĂ­nicos importados do XML ICTRP.

Back
9139
RBR-10tkjh3t
Effectiveness and durability of ready-to-use botulinum toxin A formulations (Relfydess and Alluzience) for treating moderate to severe frown lines: a randomized controlled clinical trial
Efficacy and durability of liquid formulations of botulinum toxin type A, Relabotulinumtoxin-A (Relfydess) and RTU Abobotulinumtoxin-A (Alluzience), in the treatment of moderate-to-severe dynamic glabellar lines: a randomized, controlled, triple-blind clinical study
None
Recruitment completed
Intervention
3, randomized-controlled, triple-blind
None
None
None
None
2026-04-26
2026-02-01
None
None
Centro Universitário Uningá
None
None
None
female patients aged between 25 and 50 years; presence of dynamic glabellar lines involving the procerus and corrugator muscles; no botulinum toxin injections within the last year for aesthetic or therapeutic purposes in any body region; moderate to severe glabellar lines according to the 5-point Merz scale; and no aesthetic procedures performed in the upper third of the face within the last year. 3. Moderate to severe glabellar lines according to the 5-point Merz scale; 4. No other aesthetic procedures performed in the upper third of the face within the last year.
receipt of tetanus or COVID-19 vaccination within the last three months prior to study initiation; presence of autoimmune diseases; pregnancy or breastfeeding; presence of neuromuscular disorders, such as myasthenia gravis or Lambert–Eaton syndrome; current use of medications affecting neuromuscular junctions; engagement in high-intensity physical exercise; and refusal or inability to sign the Informed Consent Form
None
None
None
None
None
2026-05-11 05:23:18